Back to News
Sep 26, 2025 4:00 PM

Your AstraZeneca Medicine Could Be Cheaper As Much As 70%

AstraZeneca Plc (NASDAQ: AZN) launched AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access their prescribed medications at a transparent cash price with home delivery.

AstraZeneca Direct will support people living with chronic conditions such as asthma, diabetes, heart failure and chronic kidney disease, and people seeking flu protection.

Starting October 1, 2025, eligible patients with prescriptions for Airsupra (albuterol/budesonide) or Farxiga (dapaglifozin) will be able to use AstraZeneca Direct to purchase these ...